<DOC>
	<DOCNO>NCT01185691</DOCNO>
	<brief_summary>The primary objective study assess safety feasibility IMPELLA 2.5 Acute Decompensated Heart Failure patient .</brief_summary>
	<brief_title>Investigating Role Impella 2.5 System Acutely Decompensated Chronic Heart Failure Patients</brief_title>
	<detailed_description />
	<mesh_term>Heart Failure</mesh_term>
	<criteria>Major 1 . Chronic heart failure patient , hospitalize due decompensated heart failure ( ADHF ) NYHA Class IIIIV symptom ( ADHF define presence least one follow symptoms/signs : dyspnea w/orthopnea , jugular venous distension , peripheral edema +2 , abdominal ascites , sign CHF chest XRay ) 2 . LVEF â‰¤ 40 % within past 3 month Major 1 . Acute Qwave myocardial infarction Acute coronary syndrome within past 30 day 2 . Cardiac surgery within past 30 day 3 . Implantation cardiac resynchronization device within past 30 day possibility implant biventricular pacer within 90 day randomization</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>May 2013</verification_date>
</DOC>